Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Drug firm ruled liable in 6-month opioid trial
Teva halts production at sterile injectables plant to address FDA concerns | FiercePharma
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva discovers sophisticated fakes of popular drug | Financial Times
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
18. Teva Pharmaceutical Industries | FiercePharma
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
D&O market faces $600mn Teva Pharmaceuticals loss
World's biggest generic-drug empire created - ISRAEL21c
Teva to cut 14,000 jobs | Business | Chemistry World
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development
Israel's Teva Seeks to Acquire Drug Manufacturer Mylan for $40 Billion | Jewish & Israel News Algemeiner.com
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
